{"id":1452,"date":"2016-11-22T05:39:03","date_gmt":"2016-11-22T05:39:03","guid":{"rendered":"http:\/\/www.getbetterbodysystem.com\/fat-loss-tips\/glaxosmithkline-seeks-u-s-approval-for-triple-lung-drug\/"},"modified":"2016-11-22T05:39:03","modified_gmt":"2016-11-22T05:39:03","slug":"glaxosmithkline-seeks-u-s-approval-for-triple-lung-drug","status":"publish","type":"post","link":"http:\/\/www.getbetterbodysystem.com\/fat-loss-tips\/glaxosmithkline-seeks-u-s-approval-for-triple-lung-drug\/","title":{"rendered":"GlaxoSmithKline seeks U.S. approval for triple lung drug"},"content":{"rendered":"<p>LONDON (Reuters) &#8211; GlaxoSmithKline said on Monday it had filed its new three-in-one inhaled lung drug for U.S. approval, putting it on track to reach the market ahead of rivals in 2017, assuming it wins a green light.<\/p>\n<div class=\"feedflare\"><a href=\"http:\/\/feeds.reuters.com\/~ff\/reuters\/healthNews?a=RK4Gf-ZCldo:bVUPndSXG3g:yIl2AUoC8zA\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/reuters\/healthNews?d=yIl2AUoC8zA\" border=\"0\" title=\"\" alt=\"\" \/><\/img><\/a> <a href=\"http:\/\/feeds.reuters.com\/~ff\/reuters\/healthNews?a=RK4Gf-ZCldo:bVUPndSXG3g:F7zBnMyn0Lo\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/reuters\/healthNews?i=RK4Gf-ZCldo:bVUPndSXG3g:F7zBnMyn0Lo\" border=\"0\" title=\"\" alt=\"\" \/><\/img><\/a> <a href=\"http:\/\/feeds.reuters.com\/~ff\/reuters\/healthNews?a=RK4Gf-ZCldo:bVUPndSXG3g:V_sGLiPBpWU\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/reuters\/healthNews?i=RK4Gf-ZCldo:bVUPndSXG3g:V_sGLiPBpWU\" border=\"0\" title=\"\" alt=\"\" \/><\/img><\/a> <\/div>\n<p><img decoding=\"async\" loading=\"lazy\" src=\"http:\/\/feeds.feedburner.com\/~r\/reuters\/healthNews\/~4\/RK4Gf-ZCldo\" height=\"1\" width=\"1\" alt=\"\" \/><br \/>\n<a rel=\"nofollow\" href=\"http:\/\/feeds.reuters.com\/~r\/reuters\/healthNews\/~3\/RK4Gf-ZCldo\/us-gsk-respiratory-idUSKBN13G0MR\">Reuters: Health News<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>LONDON (Reuters) &#8211; GlaxoSmithKline said on Monday it had filed its new three-in-one inhaled lung drug for U.S. approval, putting it on track to reach the market ahead of rivals in 2017, assuming it wins a green light. Reuters: Health News<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[634,274,2611,807,2612,2613,485],"_links":{"self":[{"href":"http:\/\/www.getbetterbodysystem.com\/wp-json\/wp\/v2\/posts\/1452"}],"collection":[{"href":"http:\/\/www.getbetterbodysystem.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.getbetterbodysystem.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.getbetterbodysystem.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.getbetterbodysystem.com\/wp-json\/wp\/v2\/comments?post=1452"}],"version-history":[{"count":0,"href":"http:\/\/www.getbetterbodysystem.com\/wp-json\/wp\/v2\/posts\/1452\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.getbetterbodysystem.com\/wp-json\/wp\/v2\/media?parent=1452"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.getbetterbodysystem.com\/wp-json\/wp\/v2\/categories?post=1452"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.getbetterbodysystem.com\/wp-json\/wp\/v2\/tags?post=1452"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}